Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001850021 | SCV002291244 | likely pathogenic | not provided | 2021-10-31 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 526 of the TNNI3K protein (p.Gly526Asp). This missense change has been observed in individual(s) with TNNI3K-related conditions (PMID: 24925317). It has also been observed to segregate with disease in related individuals. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this missense change affects TNNI3K function (PMID: 30010057). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 161447). |
OMIM | RCV000148950 | SCV000195870 | pathogenic | Atrial conduction disease | 2014-11-01 | no assertion criteria provided | literature only |